The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment outcome in the UK ALL97 trial for childhood acute lymphoblastic leukaemia; TPMT heterozygosity is not associated with secondary cancers
Автори: | Lennard, L, Cartwright, C, Wade, R, Richards, S, Mitchell, C, Kinsey, S, Eden, T, Lilleyman, J, Vora, A |
---|---|
Формат: | Conference item |
Опубліковано: |
2010
|
Схожі ресурси
Схожі ресурси
-
Detection of Thiopurine S-Methyltransferase (TPMT) Polymorphisms TPMT*3A, TPMT*3B and TPMT*3C in Children with Acute Lymphoblastic Leukemia
за авторством: Nawar S. Mohammed, та інші
Опубліковано: (2018-12-01) -
Common Polymorphism’s Analysis of Thiopurine S-Methyltransferase (TPMT) in Iranian Population
за авторством: Mehdi Azad, та інші
Опубліковано: (2009-01-01) -
Thiopurine methyltransferase genotype-phenotype discordance and thiopurine active metabolite formation in childhood acute lymphoblastic leukaemia.
за авторством: Lennard, L, та інші
Опубліковано: (2013) -
Thiopurine methyltransferase (TPMT), nudix hydrolase 15 (NUDT-15) and methylene tetrahydrofolate reductase (MTHFR)polymorphisms in children with acute lymphoblastic leukaemia
за авторством: Srikanth Marda, та інші
Опубліковано: (2022-01-01) -
Positive TPMT genotype-phenotype correlation underscores importance of TPMT genotyping for personalized thiopurine dosing
за авторством: Hui-min, Neoh, та інші
Опубліковано: (2012)